Clinical trials in Cepin

Clinical trial activity in Cepin is focused entirely on cardiovascular diseases, with studies exploring new ways to reduce heart-related events and improve long-term outcomes for people living with complex heart conditions.

• Chronic heart failure
• Heart failure with mildly reduced or preserved ejection fraction
• Heart failure with reduced ejection fraction
• Heart condition

These trials are mainly testing whether newer treatments can better control inflammation, protect the heart, and lower the risk of hospitalization or cardiovascular death.

Several studies are examining heart failure together with systemic inflammation, aiming to see whether targeted therapy can improve outcomes for patients with HFmrEF and HFpEF.

• HFmrEF
• HFpEF
• Systemic inflammation
• Cardiovascular death and heart failure events

This research is designed to evaluate a potential new treatment approach for people whose heart failure is linked with inflammatory activity.

Another important area of research is the management of heart failure in patients who cannot use standard mineralocorticoid receptor antagonists, with studies looking at both effectiveness and safety.

• HFrEF
• Finerenone
• Safety and tolerability
• Standard heart failure care

These trials are intended to expand treatment options for people with limited access to current therapies.

Research in the city also includes patients with type 2 diabetes, hypertension, and established cardiovascular disease, reflecting the close link between metabolic and heart health.

• Type 2 diabetes
• High blood pressure
• Established cardiovascular disease
• Heart-related hospital visits

These studies are focused on whether combining therapies can better prevent serious cardiovascular events in high-risk patients.

One trial is exploring whether treating iron deficiency in people with symptomatic chronic heart failure can improve survival and reduce worsening heart failure.

• Symptomatic chronic heart failure
• Iron deficiency
• Ferric derisomaltose
• Hospitalization prevention

This line of research aims to clarify the role of iron replacement as part of comprehensive heart failure care.